Skip to Main Content
TRC_Prescriber's Letter NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Drug Charts
    • First-Time Generics
    • New Drugs
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

COMING SOON: In the next few weeks, Prescriber's Letter is becoming Prescriber Insights, with all the high-quality content you trust, but delivered in profession-specific editions. As the updates push to your account, you will begin to see references to Prescriber Insights and a prompt to select your profession-specific edition.
  1. Home
  2. Browse
  3. Interactions
  4. Cardiology
  5. Antihypertensives
  6. Diuretics

Diuretics

  • Bone & Joint (68)
  • Cardiology (295)
    • Antiarrhythmics (76)
    • Antihypertensives (89)
      • ACEIs (32)
      • Aldosterone Antagonists (13)
      • Alpha-Blockers (5)
      • ARBs (30)
      • Beta-Blockers (16)
      • Calcium Channel Blockers (31)
      • Diuretics (25)
    • Antiplatelets/Anticoagulants (149)
    • Dyslipidemia Drugs (69)
    • Other (24)
  • Dermatology (61)
  • Diabetes & Endocrinology (45)
  • Gastroenterology (86)
  • Hematology & Oncology (9)
  • Infectious Diseases (246)
  • Men's Health (7)
  • Natural Medicines / Supplements / Food Interactions (141)
  • Neurology (145)
  • Nutrition & Obesity (11)
  • Psychiatry (157)
  • Resources (42)
  • Respiratory & Allergy (27)
  • Transplant Meds (12)
  • Women's Health (48)
16 - 25 of 25 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: fewer red flags when you prescribe celecoxib (Celebrex) to patients with a sulfa allergy February 2014
Article: kidney risks of NSAIDs April 2013
PL Voices: Managing the “Triple Whammy” Interaction April 2013
Commentary: The "Triple Whammy" April 2013
Article: "alert fatigue" caused by the increasing number of drug interaction warnings May 2012
PL Voices: How to Handle Drug Interaction Warnings May 2012
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Article: QT prolongation drug interactions with some antipsychotics, antiarrhythmics, antibiotics April 2010
Article: which diuretic is best in a given situation February 2009
Article: risk of renal impairment in patients taking an ACE inhibitor or ARB, diuretic, and NSAID December 2006
  • « Prev
  • 1
  • 2
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved